HomepageSHTDY • OTCMKTS
add
Sinopharm Group ADR
Vorige slotkoers
$Â 11,74
Dag-range
$Â 11,73 - $Â 11,86
Jaar-range
$Â 10,13 - $Â 16,31
Beurswaarde
57,11Â mld. HKD
Gem. volume
16,90K
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CNY) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 141,66Â mld. | -3,81% |
Bedrijfskosten | 6,72Â mld. | -6,59% |
Netto inkomsten | 1,46Â mld. | 2,59% |
Netto winstmarge | 1,03 | 7,29% |
Winst per aandeel | — | — |
EBITDA | 3,70Â mld. | -5,19% |
Effectief belastingtarief | 23,38% | — |
Balans
Totale activa
Totale passiva
| (CNY) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 45,36Â mld. | -32,44% |
Totale activa | 415,08 mld. | — |
Totale passiva | 285,93 mld. | — |
Totaal aandelenvermogen | 129,16 mld. | — |
Uitstaande aandelen | 3,12 mld. | — |
Koers-boekwaardeverhouding | 0,45 | — |
Rendement op activa | 1,96% | — |
Rendement op kapitaal | 3,85% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CNY) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 1,46Â mld. | 2,59% |
Operationele kasstroom | -34,28Â mld. | 27,81% |
Kasstroom uit beleggingen | 617,49Â mln. | 141,09% |
Kasstroom uit financiering | 12,88Â mld. | -41,88% |
Nettomutatie in liquide middelen | -20,78Â mld. | 17,10% |
Vrije kasstroom | -14,13 mld. | — |
Over
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Opgericht
2003
Website
Werknemers
108.217
